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 Lecithin retinol acyltransferase (LRAT), a 25.3 kDa pro-
tein found mainly in the retinal pigment epithelium and liver,
catalyzes the formation of retinyl esters from all-trans retinol
[1]. In the visual cycle, these retinyl esters are converted to
11-cis retinol by the isomerase activity of RPE65 [2]. The 11-
cis retinol is subsequently converted to 11-cis retinaldehyde
which is transferred to the photoreceptors where it serves as
the chromophore in rod and cone opsins [3].
Two groups have reported a total of four patients with
LRAT mutations. One found a missense mutation, Ser175Arg,
in two unrelated homozygote patients with recessive early-
onset severe retinal dystrophy [4]. Analysis of the correspond-
ing mutant LRAT protein expressed in vitro showed that it
had greatly reduced enzyme activity [4]. The same paper also
described an obviously null frameshift mutation (396delAA)
in a third patient who was a heterozygote with no mutation
discovered in the other allele [4]. The second group found a
patient with Leber congenital amaurosis (LCA) posessing a
homozygous frameshift mutation (c.217_218delAT), which
results in an early stop codon and likely would encode a non-
functional protein [5]. Support for interpreting these null mu-
tations as the causes of the patients’ retinal degeneration comes
from the analysis of transgenic mice lacking this gene; these
mice have shortened photoreceptor outer segments and early
loss of rod and cone photoreceptor function [6,7].
The term “early-onset severe retinal dystrophy” [4], can
refer to either LCA or severe autosomal recessive retinitis
pigmentosa (ARRP). Both LCA and ARRP are genetically
heterogenous and many of the responsible genes remain uni-
dentified. In order to better determine the proportion of pa-
tients with LCA or ARRP having mutations in LRAT, we per-
formed a survey of patients with the clinical diagnosis of LCA
and ARRP to find the prevalence of LRAT mutations associ-
ated with these two retinal diseases.
METHODS
 This study conformed to the Declaration of Helsinki. We
evaluated leukocyte DNA from 82 unrelated patients with LCA
and 190 unrelated patients with ARRP. Our patients with LCA
typically had nystagmus and visual acuities less than 20/200,
while those with ARRP typically had no nystagmus and vi-
sion better than 20/200 at the initial visit. Many of these pa-
tients had been previously evaluated for mutations in the
PDE6A [8], PDE6B [9], CRX [10], RPE65 [11], ELOVL4 [12],
CNCG1 [13], USH2A [14], NRL [15], RPGRIP [16], USH3A
[17], RHO [18], RDS [19], RDH5 [20], CRALBP [21], and
RGR [22] genes; patients with definitely pathogenic mutations
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TABLE 1. PRIMER SEQUENCES
Exon   Direction      Sequence (5'-3')
----   ---------   -----------------------
1      Sense       CTCGACGGCCATAAAAAGTC
1      Antisense   AAAGACACCACCTCCAGCAT
2a     Sense       TACTTTGCGCCGTACCTCAC
2a     Antisense   GTAGGCGAAGTCCTCCACTG
2b     Sense       GAAGGTGGTCTCCAACAAGC
2b     Antisense   GGGGAAGAGAAAAGGTCAGG
3      Sense       CAGAAAATAGCTGGGAAAACTGA
3      Antisense   AAGCACTTTGCGTGATTCCT
The coding regions of lecithin retinol acyltransferase was polymerase
chain reaction amplified from the leukocyte DNA of 82 unrelated
patients with Leber congenital amaurosis and 190 unrelated patients
with autosomal recessive retinitis pigmentosa using the 4 pairs of
primers shown in this table.
588in one of those genes were excluded from this study. For each
patient, the coding region of LRAT along with flanking intronic
sequences, the entire 5' untranslated region (UTR), and 129
bp of the 3' UTR were PCR-amplified using 4 pairs of primers
(Table 1). The amplicons were directly sequenced in one di-
rection. Any sequence changes found were confirmed by se-
quencing in the opposite direction and were evaluated for their
likelihood in altering splicing of the LRAT transcript using
splice site prediction software found at the web site NNSPLICE
0.9 version [23].
RESULTS
 We found six sequence variants in LRAT in eleven ARRP pa-
tients and two LCA patients (Table 2). Most of the changes
were in introns or in untranslated regions of the exons. The
only change in the coding region was an isocoding change in
codon Glu114 (GAG>GAA; c.342) found in two LCA patients
(all heterozygotes) and in five ARRP patients (4 heterozygotes
and one homozygote), for a rare allele frequency overall of
1.5%. Splice site prediction software indicated that none of
these changes were likely to alter RNA splicing (the splicing
index was changed less than or equal to 0.01 compared to the
normal sequence).
DISCUSSION
 Of the 6 sequence changes we found in LRAT, only one was
found in the coding region, and that was the isocoding change
in Glu114. Another group found this change in one ARRP
patient, in one patient with macular degeneration, and in one
patient with cone-rod dystrophy, all heterozygotes [24]. Fur-
thermore, that same study found Glu114Glu in an unaffected
homozygote [24]. Three previous studies by other groups also
found the Glu114Glu change [4,5,25]. It was interpreted as a
nonpathogenic polymorphism because it was found in 2.5%
of alleles in retinal dystrophy patients, 2.7% of alleles in RP
and flecked retinal dystrophy patients, and 3% of alleles in
LCA patients analyzed; these allele frequencies are similar to
the frequency of 1.5% found in our survey [4,5,25]. (Note: in
the paper by Perrault et al. [25], this polymorphism was incor-
rectly labeled as Ser175Pro (unpublished communication from
the authors)). The other changes we found are also unlikely to
be pathogenic since they occur in introns away from consen-
sus splice donor and acceptor sites or in the non-coding re-
gions of exons; none is predicted to affect splicing.
Table 3 summarizes the results from 30 published studies
(including this one) that describe searches among nine or more
patients for mutations in eleven genes known to cause LCA
(or early-onset retinal dystrophy which we have grouped to-
gether with LCA for this table). The two genes that account
for the largest proportions of cases are CEP290 (21% of cases
overall) encoding a centrosomal protein and GUCY2D encod-
ing guanylate cyclase (13% of cases). Figure 1 is a pie chart
with the estimated proportions of LCA patients caused by each
gene based on these 30 studies. It is noteworthy that approxi-
mately a quarter of all patients with LCA likely have respon-
sible mutations in genes that remain unidentified.
Table 3 lists three studies that analyzed LRAT in a com-
bined total of 314 LCA patients. No patients with LRAT muta-
tions were found. Nevertheless, there are 4 reported LCA pa-
tients with pathogenic LRAT mutations [4,5]. Thompson et al.
[4] reported 3 unrelated LCA patients with LRAT mutations,
but this paper is not included in Table 3 because the number
of LCA patients evaluated was not provided. Senechal et al.
[5] reported one patient with LCA due to LRAT, but this report
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TABLE 2. SEQUENCE CHANGES FOUND IN LRAT
Exon   Sequence change         Number of heterozygotes (patient IDs)         Number of homozygotes
----   ---------------------   -------------------------------------------   ---------------------
1      5’UTR-15C>T             2 ARRP (003-147, 003-185)                       0
1      IVS1+7A>C               2 ARRP (003-069, 003-161)                       0
1      IVS1+13G>T              1 ARRP (003-178)                                0
1      5’UTR-156C>G            1 ARRP (003-182)                                0
2b     Glu114Glu c.342G>A      4 ARRP (003-089, 003-197, 003-285, 003-371)     1 ARRP (003-228)
                               + 2 LCA (048-020, 048-065)
3      3’UTR+3T>G              1 ARRP (003-064)                                0
Six sequence changes in LRAT were found among 11 autosomal recessive retinitis pigmentosa patients and 2 Leber congenital amaurosis
patients.
Figure 1. Estimated proportions of patients with Leber congenital
amaurosis caused by the 11 identified Leber congenital amaurosis
genes.  This figure uses overall frequencies from Table 3. Eleven
identified genes are responsible for approximately 75% of Leber
congenital amaurosis cases; the gene(s) responsible for the remain-
ing 25% of cases remain(s) unknown. CEP290 is responsible for the
greatest number of cases (21%). The proportion of cases caused by
LCAT mutations has been arbitrarily set at 1% (see Discussion).
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TABLE 3. PROPORTIONS OF PATIENTS WITH MUTATIONS IN IDENTIFIED LEBER CONGENITAL AMAUROSIS GENES
                                                                                                                        Total
                                                                                                                       patients
   Study/Gene       AIPL1    CEP290    CRB1     CRX     GUCY2D    IMPDH1   LRAT    RDH12    RPE65    RPGRIP1   TULP1   screened
-----------------   ------   ------   ------   ------   -------   ------   -----   -----   -------   -------   -----   --------
Marlhens et al.                                                                            1                           12
1997 [30]                                                                                  (8%)
Morimura et al.                                                                            7                           45
1998 [11]                                                                                  (16%)
Freund et al.                                  2                                                                       74
1998 [31]                                      (3%)
Swaroop et al.                                 1                                                                       9
1999 [32]                                      (11%)
Lewis et al.                                                                                                   0       25
1999 [33]                                                                                                      (0%)
Dharmaraj et al.                               2        6                                  3                           100
2000 [34]                                      (2%)     (6%)                               (3%)
Sohocki et al.      11                                                                                                 188
2000 [35]           (6%)
Lotery et al.                                  5        11                                 12                          176
2000 [36]                                      (3%)     (6%)                               (7%)
Silva et al.                                   2                                                                       74
2000 [37]                                      (3%)
Perrault et al.                                         24                                                             118
2000 [38]                                               (20%)
Thompson et al.                                                                            13                          114
2000 [39]                                                                                  (11%)
Ruiz et al.                                                                0                                           38
2001 [24]                                                                  (0%)
Zhang et al.                                   1                                                                       27
2001 [40]                                      (4%)
Rivolta et al.                                 2                                                                       62
2001 [10]                                      (3%)
Dryja et al.                                                                                         3                 57
2001 [16]                                                                                            (5%)
den Hollander et                      7                                                                                52
al. 2001 [41]                        (13%)
Simovich et al.                                                                            8                           98
2001 [42]                                                                                  (8%)
Gerber et al.                                                                                        8                 142
2001 [43]                                                                                            (6%)
Sohocki et al.      3                          1                                                                       27
2001 [44]           (11%)                      (4%)
Sitorus et al.      1                                   0                                  2                           21
2003 [45]           (5%)                                (0%)                               (10%)
Hanein et al.       6                 18       1        38                                 11        8         3       179
2004 [46]           (3%)              (10%)    (1%)     (21%)                              (6%)      (4%)      (2%)
Dharmaraj et al.    26                                                                                                 303
2004 [47]           (9%)
Perrault et al.                                                            0       8                                   179
2004 [25]                                                                  (0%)    (4%)
den Hollander et                      0                                                                                44
al. 2004 [48]                         (0%)
Zernant et al.      16                11       3        24                                 5         10                205
2005 [49]           (6%)              (5%)     (1%)     (12%)                              (2%)      (5%)
Booij et al.                          1                 1                                  2                           9
2005 [50]                             (11%)             (11%)                              (22%)
Bowne et al.                                                      2                                                    24
2006 [51]                                                         (8%)
Yzer et al.         3                 9        0        6                          0*      1         0                 58*
2006 [29]           (5%)              (15%)    (0%)     (10%)                      (0%)    (2%)      (0%)
den Hollander et             16                                                                                        76
al. 2006 [52]                (21%)
Sweeney et al.                                                             0                                           97**
2007                                                                       (0%)
Totals              66/981   16/76    46/547   20/991   110/866   2/24     0/314   8/201   65/1017   29/641    3/204
Overall Frequency   7%       21%      8%       2%       13%       8%       0%***   4%      6%        5%        1%      75%****
The table includes surveys of patients described as having Leber congenital amaurosis (LCA) or early-onset retinal dystrophy. Patients with a
detected mutation in one or both alleles in a given gene are considered to have disease due to that gene. We exclude reports of surveys of fewer
than nine patients; e.g., we exclude the reports of single patients with mutations in CRX [26] and LRAT [5]. We also do not include papers for
which pathogenic mutations could not be distinguished from nonpathogenic rare variants (e.g., the survey of CRB1 by Lotery et al. [27]) or
papers that did not specify the number of unrelated LCA or early-onset retinal dystrophy patients screened (e.g. Thompson et al. [4] and Galvin
et al.[28]). The single asterisk indicates that in the study by Yzer et al. [29], 58 patients were evaluated for the listed genes except for RDH12,
for which only 22 were evaluated. Double asterisk indicates the 97 patients include 82 patients in our current screen and 15 LCA patients
previously solved for mutations in other genes and not included in our screen. Triple asterisk indicates the percentage of LCA patients with
LRAT mutations is indicated as zero but is definitely higher (see text). Four asterisks indicate the total proportion of patients with mutations
identified.
590was also not included in Table 3 because only one LCA pa-
tient was evaluated. Based on these reports and the studies
such as ours that found no LCA patients with LRAT muta-
tions, it is clear that LRAT mutations account for a very small
percentage of LCA cases. In Figure 1, we have arbitrarily set
the percentage at 1%.
Our not finding mutations in a set of 190 unrelated pa-
tients with ARRP indicates that LRAT is not a common cause
of that disease as well. Furthermore, Ruiz et al. (2001) [24]
found no pathogenic mutations in 91 patients with retinitis
pigmentosa, 58 patients with cone-rod dystrophy, or 93 pa-
tients with age-related macular degeneration. Senechal et al.
(2006) [5] also found no pathogenic LRAT mutations in 134
patients with simplex or multiplex retinitis pigmentosa or in
82 patients with flecked retinal dystrophy. Based on our large
survey together with the surveys in the literature, one may
confidently conclude that LRAT-caused retinal degeneration
is very rare. This rarity can have implications for the develop-
ment of therapies for patients with this condition. Efficacy
studies for proposed therapies may have to be based on re-
sults from only a few patients or based on results from similar
therapies developed for patients with other defects in the vita-
min A cycle affecting the RPE.
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